| scholarly article | Q13442814 |
| P50 | author | Todd Lencz | Q37652358 |
| Toshikazu Ikuta | Q47352888 | ||
| Katherine H. Karlsgodt | Q47503140 | ||
| John M. Kane | Q52274733 | ||
| Miklos Argyelan | Q60649299 | ||
| Delbert G Robinson | Q88012193 | ||
| Philip R. Szeszko | Q114270635 | ||
| P2093 | author name string | Anil K Malhotra | |
| Juan A Gallego | |||
| Deepak K Sarpal | |||
| P2860 | cites work | Thresholding of statistical maps in functional neuroimaging using the false discovery rate | Q28208414 |
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. | Q30416778 | ||
| Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations | Q30455338 | ||
| Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics | Q30596256 | ||
| Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis | Q33762485 | ||
| Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia | Q33957624 | ||
| Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia | Q33963430 | ||
| Patterns of cerebral blood flow in schizophrenia | Q34351973 | ||
| Dopamine in schizophrenia: a review and reconceptualization | Q34568816 | ||
| Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia | Q34660641 | ||
| Half a century of antipsychotics and still a central role for dopamine D2 receptors | Q35595235 | ||
| Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET | Q36449077 | ||
| Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia | Q36621056 | ||
| The nature of dopamine dysfunction in schizophrenia and what this means for treatment | Q37062793 | ||
| Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. | Q37092462 | ||
| Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia | Q37441628 | ||
| Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia | Q38466601 | ||
| D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis | Q42056580 | ||
| Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging. | Q42948981 | ||
| Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study | Q42984373 | ||
| Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex | Q44603419 | ||
| Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication | Q44676235 | ||
| Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis | Q45170233 | ||
| Links among resting-state default-mode network, salience network, and symptomatology in schizophrenia | Q45852908 | ||
| Schizophrenia and the brain's control network: aberrant within- and between-network connectivity of the frontoparietal network in schizophrenia | Q46206573 | ||
| Dysfunction of ventral striatal reward prediction in schizophrenia | Q46684383 | ||
| DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients | Q46973173 | ||
| Alterations of the brain reward system in antipsychotic naïve schizophrenia patients | Q48002568 | ||
| Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia | Q48094554 | ||
| Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis | Q48394255 | ||
| The formation of abnormal associations in schizophrenia: neural and behavioral evidence | Q48402897 | ||
| Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing | Q48731793 | ||
| Exploring the neural correlates of delusions of reference | Q48955172 | ||
| Task-related fronto-striatal functional connectivity during working memory performance in schizophrenia | Q49057066 | ||
| Functional connectivity of human striatum: a resting state FMRI study. | Q50639138 | ||
| Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study. | Q51892558 | ||
| Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia. | Q51968737 | ||
| Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. | Q53558839 | ||
| Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain | Q71673863 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 5-13 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia | |
| P478 | volume | 72 |
| Q90214688 | A Dissociation in Effects of Risperidone Monotherapy on Functional and Anatomical Connectivity Within the Default Mode Network |
| Q89702860 | A Network Neuroscience of Neurofeedback for Clinical Translation |
| Q36994859 | Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study |
| Q47984517 | Aberrant Hyperconnectivity in the Motor System at Rest Is Linked to Motor Abnormalities in Schizophrenia Spectrum Disorders |
| Q36382573 | Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone |
| Q37430456 | Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms |
| Q58612318 | Altered functional connectivity between sub-regions in the thalamus and cortex in schizophrenia patients measured by resting state BOLD fMRI at 7T |
| Q89135940 | Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia |
| Q92245100 | Association Between Duration of Untreated Psychosis and Frontostriatal Connectivity During Maintenance of Visuospatial Working Memory |
| Q36749821 | Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
| Q47195853 | Attenuated resting-state functional connectivity in patients with childhood- and adult-onset schizophrenia |
| Q31112799 | Auditory verbal hallucinations: neuroimaging and treatment. |
| Q36838322 | Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. |
| Q57174550 | Biological Predictors of Clozapine Response: A Systematic Review |
| Q90400263 | Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls |
| Q33718818 | Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature |
| Q91585300 | Cerebellar-cortical dysconnectivity in resting-state associated with sensorimotor tasks in schizophrenia |
| Q36983379 | Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory |
| Q37124963 | Classifying Schizophrenia Using Multimodal Multivariate Pattern Recognition Analysis: Evaluating the Impact of Individual Clinical Profiles on the Neurodiagnostic Performance |
| Q36817163 | Cognitive Behavioral Therapy Normalizes Functional Connectivity for Social Threat in Psychosis |
| Q39566093 | Connectivity of the anterior insula differentiates participants with first-episode schizophrenia spectrum disorders from controls: a machine-learning study. |
| Q37347814 | Connectomic markers of disease expression, genetic risk and resilience in bipolar disorder |
| Q31138746 | Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies |
| Q89094851 | Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia |
| Q52573337 | Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study. |
| Q45945607 | Differences Between Schizophrenic and Normal Subjects Using Network Properties from fMRI. |
| Q55037247 | Differential Resting-State Connectivity Patterns of the Right Anterior and Posterior Dorsolateral Prefrontal Cortices (DLPFC) in Schizophrenia. |
| Q92667174 | Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site FMRI data |
| Q36481738 | Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia |
| Q43226165 | Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia |
| Q93047439 | Distinct neural networks associated with obsession and delusion: a connectome-wide association study |
| Q39795188 | Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia |
| Q36690658 | Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia. |
| Q37370978 | Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis |
| Q90030614 | Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia |
| Q91574487 | Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia |
| Q47335970 | Effort-Based Reinforcement Processing and Functional Connectivity Underlying Amotivation in Medicated Patients with Depression and Schizophrenia |
| Q92704391 | Electroconvulsive Therapy and Schizophrenia: A Systematic Review |
| Q33718917 | Electroconvulsive therapy-induced brain functional connectivity predicts therapeutic efficacy in patients with schizophrenia: a multivariate pattern recognition study |
| Q36326116 | Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients |
| Q55129875 | Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. |
| Q57313396 | Frequency specific resting state functional abnormalities in psychosis |
| Q93262850 | Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study |
| Q47174121 | Functional Connectivity of Cognitive Brain Networks in Schizophrenia during a Working Memory Task |
| Q89448397 | Functional Connectivity of the Striatum as a Neural Correlate of Symptom Severity in Patient with Obsessive-Compulsive Disorder |
| Q92518217 | Functional brain networks in never-treated and treated long-term Ill schizophrenia patients |
| Q41866829 | Functional connectivity as a means to delineate differences between treatment-resistant and treatment-responsive schizophrenia |
| Q47388815 | Functional dysconnectivity of the limbic loop of frontostriatal circuits in first-episode, treatment-naive schizophrenia |
| Q95270749 | Hippocampal Resting State Functional Connectivity in Patients With Schizophrenia and Unaffected Family Members |
| Q41990130 | Identifying multimodal signatures associated with symptom clusters: the example of the IMAGEMEND project |
| Q104478809 | Improvement in prefrontal thalamic connectivity during the early course of the illness in recent-onset psychosis: a 12-month longitudinal follow-up resting-state fMRI study |
| Q58865361 | In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia |
| Q91464071 | Increased amygdala-visual cortex connectivity in youth with persecutory ideation |
| Q89572022 | Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic Schizophrenia |
| Q47734586 | Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action |
| Q47398245 | Ketamine-induced changes in connectivity of functional brain networks in awake female nonhuman primates: a translational functional imaging model. |
| Q92403485 | Long-Range Temporal Correlations in Resting State Beta Oscillations are Reduced in Schizophrenia |
| Q38650161 | Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features |
| Q36740180 | Medial Prefrontal and Anterior Insular Connectivity in Early Schizophrenia and Major Depressive Disorder: A Resting Functional MRI Evaluation of Large-Scale Brain Network Models |
| Q37429365 | Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia |
| Q57054018 | Motivational deficits in schizophrenia relate to abnormalities in cortical learning rate signals |
| Q54965021 | Multi-Site Diagnostic Classification of Schizophrenia Using Discriminant Deep Learning with Functional Connectivity MRI. |
| Q37644486 | Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations |
| Q89314064 | Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies |
| Q37009643 | Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism. |
| Q38787538 | Predicting individual brain functional connectivity using a Bayesian hierarchical model |
| Q95941878 | Predicting individual improvement in schizophrenia symptom severity at 1-year follow-up: Comparison of connectomic, structural, and clinical predictors |
| Q90092071 | Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges |
| Q38745478 | Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia. |
| Q60062678 | Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) |
| Q57054567 | Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study |
| Q37625470 | Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia |
| Q56959104 | Schizophrenia |
| Q64085157 | Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms |
| Q56969267 | Schizotypal Traits are Linked to Dopamine-Induced Striato-Cortical Decoupling: A Randomized Double-Blind Placebo-Controlled Study |
| Q91961363 | Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis |
| Q91211752 | Structural similarity networks predict clinical outcome in early-phase psychosis |
| Q92141044 | Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS) |
| Q59796668 | The Functional Connectivity Between the Nucleus Accumbens and the Ventromedial Prefrontal Cortex as an Endophenotype for Bipolar Disorder |
| Q92480512 | The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research |
| Q91130303 | The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study |
| Q49873690 | The role of fMRI in drug development |
| Q90501868 | Transdiagnostic Prediction of Affective, Cognitive, and Social Function Through Brain Reward Anticipation in Schizophrenia, Bipolar Disorder, Major Depression, and Autism Spectrum Diagnoses |
| Q89158516 | Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity |
| Q89515143 | Ultrastructural evidence for glutamatergic dysregulation in schizophrenia |
| Q55023835 | What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? |
| Q89363812 | [What role for paraclinical investigations within clinical trials conducted in psychiatric patients?] |
Search more.